Targeting mitochondrial dysfunction as in aging and glaucoma

Drug Discovery Today

Volumn 19, Issue 10, 2014, Pages 1613-1622

  Osborne, Neville N ^a   Álvarez, Claudia Núñez ^a   Del Olmo Aguado, Susana ^a  

^a Fundacion de Investigacion Oftalmologica   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MAMMALIAN TARGET OF RAPAMYCIN; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; TARGET OF RAPAMYCIN KINASE;

AGING; DISORDERS OF MITOCHONDRIAL FUNCTIONS; DNA DAMAGE; ELECTRON; GLAUCOMA; HUMAN; MITOCHONDRION; NERVE DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PHAGOCYTOSIS; PHOTORECEPTOR; PHOTOTHERAPY; RED LIGHT; RETINA GANGLION CELL; REVIEW; ANIMAL; METABOLISM; OPEN ANGLE GLAUCOMA;

AGING; ANIMALS; GLAUCOMA, OPEN-ANGLE; HUMANS; MITOCHONDRIA; RETINAL GANGLION CELLS; TOR SERINE-THREONINE KINASES;

EID: 84908610190     PISSN: 13596446     EISSN: 18785832     Source Type: Journal    
DOI: 10.1016/j.drudis.2014.05.010     Document Type: Review

References (120)

1. Weinreb, R.N. and Khaw, P.T. (2004) Primary open-angle glaucoma. Lancet 363, 1711-1720
2. Flammer, J. et al. (2002) The impact of ocular blood flow in glaucoma. Prog. Retin. Eye Res. 21, 359-393
3. Pache, M. and Flammer, J. (2006) A sick eye in a sick body? Systemic findings in patients with primary open-angle glaucoma. Surv. Ophthalmol. 51, 179-212
4. Mozaffarieh, M. et al. (2008) The potential value of natural antioxidative treatment in glaucoma. Surv. Ophthalmol. 53, 479-505
5. Osborne, N.N. et al. (2006) A hypothesis to suggest that light is a risk factor in glaucoma and the mitochondrial optic neuropathies. Br. J. Ophthalmol. 90, 237-241
6. Osborne, N.N. (2010) Mitochondria: their role in ganglion cell death and survival in primary open angle glaucoma. Exp. Eye Res. 90, 750-757
7. Casson, R.J. et al. (2012) Definition of glaucoma: clinical and experimental concepts. Clin. Exp. Ophthalmol. 40, 341-349
8. Nickells, R.W. et al. (2012) Under pressure: cellular and molecular responses during glaucoma, a common neurodegeneration with axonopathy. Annu. Rev. Neurosci. 35, 153-179
9. Quigley, H.A. (1999) Neuronal death in glaucoma. Prog. Retin. Eye Res. 18, 39-57
10. Osborne, N.N. et al. (2008) Light affects mitochondria to cause apoptosis to cultured cells: possible relevance to ganglion cell death in certain optic neuropathies. J. Neurochem. 105, 2013-2028
11. Albers, D.S. and Beal, M.F. (2000) Mitochondrial dysfunction and oxidative stress in aging and neurodegenerative disease. J. Neural. Transm. Suppl. 59, 133-154
12. Moreira, P.I. et al. (2007) Alzheimer's disease: a lesson from mitochondrial dysfunction. Antioxid. Redox Signal. 9, 1621-1630
13. Moreira, P.I. et al. (2010) Mitochondria: a therapeutic target in neurodegeneration. Biochim. Biophys. Acta 1802, 212-220
14. Sullivan, P.G. et al. (1998) Traumatic brain injury alters synaptic homeostasis: implications for impaired mitochondrial and transport function. J. Neurotrauma 15, 789-798
15. Andrews, R.M. et al. (1999) Histochemical localisation of mitochondrial enzyme activity in human optic nerve and retina. Br. J. Ophthalmol. 83, 231-235
16. Bristow, E.A. et al. (2002) The distribution of mitochondrial activity in relation to optic nerve structure. Arch. Ophthalmol. 120, 791-796
17. Carelli, V. et al. (2004) Mitochondrial dysfunction as a cause of optic neuropathies. Prog. Retin. Eye Res. 23, 53-89
18. Wang, J. and Deretic, D. (2014) Molecular complexes that direct rhodopsin transport to primary cilia. Prog. Retin. Eye Res. 38, 1-19
19. Corbisier, P. and Remacle, J. (1993) Influence of the energetic pattern of mitochondria in cell ageing. Mech. Ageing Dev. 71, 47-58
20. Lee, H.C. and Wei, Y.H. (2012) Mitochondria and aging. Adv. Exp. Med. Biol. 942, 311-327
21. Gadaleta, M.N. et al. (1998) Aging and mitochondria. Biochimie 80, 863-870
22. Harman, D. (1981) The aging process. Proc. Natl. Acad. Sci. U. S. A. 78, 7124-7128
23. Lass, A. and Sohal, R.S. (1999) Comparisons of coenzyme Q bound to mitochondrial membrane proteins among different mammalian species. Free Radic. Biol. Med. 27, 220-226
24. Rolfe, D.F. and Brand, M.D. (1997) The physiological significance of mitochondrial proton leak in animal cells and tissues. Biosci. Rep. 17, 9-16
25. Nohl, H. et al. (1998) The biochemical, pathophysiological, and medical aspects of ubiquinone function. Ann. N. Y. Acad. Sci. 854, 394-409
26. Barja, G. and Herrero, A. (2000) Oxidative damage to mitochondrial DNA is inversely related to maximum life span in the heart and brain of mammals. FASEB J. 14, 312-318
27. Bodnar, A.G. et al. (1998) Extension of life-span by introduction of telomerase into normal human cells. Science 279, 349-352
28. Kong, Y.X. et al. (2012) Impact of aging and diet restriction on retinal function during and after acute intraocular pressure injury. Neurobiol. Aging 33, 1126
29. Baltan, S. et al. (2010) Metabolic vulnerability disposes retinal ganglion cell axons to dysfunction in a model of glaucomatous degeneration. J. Neurosci. 30, 5644-5652
30. Tezel, G. et al. (2007) Mechanisms of immune system activation in glaucoma: oxidative stress-stimulated antigen presentation by the retina and optic nerve head glia. Invest. Ophthalmol. Vis. Sci. 48, 705-714
31. Dietrich, M.O. and Horvath, T.L. (2010) The role of mitochondrial uncoupling proteins in lifespan. Pflügers Archiv. Eur. J. Physiol. 459, 269-275
32. Navarro, A. and Boveris, A. (2007) The mitochondrial energy transduction system and the aging process. Am. J. Physiol. Cell Physiol. 292, C670-C686
33. Boveris, A. and Navarro, A. (2008) Brain mitochondrial dysfunction in aging. IUBMB Life 60, 308-314
34. Browne, S.E. (2008) Mitochondria and Huntington's disease pathogenesis: insight from genetic and chemical models. Ann. N. Y. Acad. Sci. 1147, 358-382
35. Walker, F.O. (2007) Huntington's disease. Lancet 369, 218-228
36. Strauss, K.M. et al. (2005) Loss of function mutations in the gene encoding Omi/HtrA2 in Parkinson's disease. Hum. Mol. Genet. 14, 2099-2111
37. Martins, L.M. et al. (2004) Neuroprotective role of the Reaper-related serine protease HtrA2/Omi revealed by targeted deletion in mice. Mol. Cell Biol. 24, 9848-9862
38. Tuck, M.W. and Crick, R.P. (2003) The projected increase in glaucoma due to an ageing population. Ophthalmic. Physiol. Opt. 23, 175-179
39. Tielsch, J.M. et al. (1991) Socioeconomic status and visual impairment among urban Americans. Baltimore Eye Survey Research Group. Arch. Ophthalmol. 109, 637-641
40. Leske, M.C. et al. (2007) Predictors of long-term progression in the early manifest glaucoma trial. Ophthalmology 114, 1965-1972
41. Abu-Amero, K.K. et al. (2006) Mitochondrial abnormalities in patients with primary open-angle glaucoma. Invest. Ophthalmol. Vis. Sci. 47, 2533-2541
42. Lascaratos, G. et al. (2012) Mitochondrial dysfunction in glaucoma: understanding genetic influences. Mitochondrion 12, 202-212
43. Fingert, J.H. (2011) Primary open-angle glaucoma genes. Eye (Lond.) 25, 587-595
44. Gibson, J. et al. (2012) Genome-wide association study of primary open angle glaucoma risk and quantitative traits. Mol. Vis. 18, 1083-1092
45. Flammer, J. and Mozaffarieh, M. (2007) What is the present pathogenetic concept of glaucomatous optic neuropathy? Surv. Ophthalmol. 52 (Suppl. 2), 162-173
46. Mookherjee, S. et al. (2012) Molecular basis for involvement of CYP1B1 in MYOC upregulation and its potential implication in glaucoma pathogenesis. PLoS One 7, e45077
47. Osborne, N.N. et al. (2004) Retinal ischemia: mechanisms of damage and potential therapeutic strategies. Prog. Retin. Eye Res. 23, 91-147
48. Chidlow, G. et al. (2007) Pharmacological neuroprotection for glaucoma. Drugs 67, 725-759
49. Osborne, N.N. (2008) Pathogenesis of ganglion cell death in glaucoma and neuroprotection: focus on ganglion cell axonal mitochondria. Prog. Brain Res. 173, 339-352
50. Osborne, N.N. and del Olmo-Aguado, S. (2013) Maintenance of retinal ganglion cell mitochondrial functions as a neuroprotective strategy in glaucoma. Curr. Opin. Pharmacol. 13, 16-22
51. Baltmr, A. et al. (2010) Neuroprotection in glaucoma - is there a future role? Exp. Eye Res. 91, 554-566
52. Chrysostomou, V. et al. (2013) Oxidative stress and mitochondrial dysfunction in glaucoma. Curr. Opin. Pharmacol. 13, 12-15
53. Ozdemir, G. et al. (2009) Retinal oxidative stress induced by intraocular hypertension in rats may be ameliorated by brimonidine treatment and N-acetyl cysteine supplementation. J. Glaucoma 18, 662-665
54. Russo, A. et al. (2008) Latanoprost ophthalmic solution in the treatment of open angle glaucoma or raised intraocular pressure: a review. Clin. Ophthalmol. 2, 897-905
55. Ramdas, W.D. et al. (2012) Nutrient intake and risk of open-angle glaucoma: the Rotterdam Study. Eur. J. Epidemiol. 27, 385-393
56. Szeto, H.H. (2008) Development of mitochondria-targeted aromatic-cationic peptides for neurodegenerative diseases. Ann. N. Y. Acad. Sci. 1147, 112-121
57. Reddy, P.H. (2008) Mitochondrial medicine for aging and neurodegenerative diseases. Neuromol. Med. 10, 291-315
58. Singhal, A. et al. (2013) Nanoparticle-mediated catalase delivery protects human neurons from oxidative stress. Cell Death Dis. 4, e903
59. Murphy, M.P. and Smith, R.A. (2007) Targeting antioxidants to mitochondria by conjugation to lipophilic cations. Annu. Rev. Pharmacol. Toxicol. 47, 629-656
60. Reddy, P.H. and Beal, M.F. (2008) Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol. Med. 14, 45-53
61. Smith, R.A. and Murphy, M.P. (2010) Animal and human studies with the mitochondria-targeted antioxidant MitoQ. Ann. N. Y. Acad. Sci. 1201, 96-103
62. Klopstock, T. et al. (2011) A randomized placebo-controlled trial of idebenone in Leber's hereditary optic neuropathy. Brain 134, 2677-2686
63. Clark, J. and Simon, D.K. (2009) Transcribe to survive: transcriptional control of antioxidant defense programs for neuroprotection in Parkinson's disease. Antioxid. Redox Signal. 11, 509-528
64. Cort, A. et al. (2010) Suppressive effect of astaxanthin on retinal injury induced by elevated intraocular pressure. Regul. Toxicol. Pharmacol. 58, 121-130
65. Zhang, B. et al. (2008) Orally administered epigallocatechin gallate attenuates retinal neuronal death in vivo and light-induced apoptosis in vitro. Brain Res. 1198, 141-152
66. Dogan, S. et al. (2011) Manganese porphyrin reduces retinal injury induced by ocular hypertension in rats. Exp. Eye Res. 93, 387-396
67. Osborne, N.N. et al. (2010) Light effects on mitochondrial photosensitizers in relation to retinal degeneration. Neurochem. Res. 35, 2027-2034
68. Schober, M.S. et al. (2008) Bioenergetic-based neuroprotection and glaucoma. Clin. Exp. Ophthalmol. 36, 377-385
69. Schintu, N. et al. (2009) PPAR-gamma-mediated neuroprotection in a chronic mouse model of Parkinson's disease. Eur. J. Neurosci. 29, 954-963
70. Cui, L. et al. (2006) Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127, 59-69
71. Dixon, S.J. and Stockwell, P.R. (2014) The role of iron and reactive oxygen species in cell death. Nat. Chem. Biol. 10, 9-17
72. Chong, Z.Z. et al. (2010) Mammalian target of rapamycin: hitting the bull's-eye for neurological disorders. Oxid. Med. Cell Longev. 3, 374-391
73. Benjamin, D. et al. (2011) Rapamycin passes the torch: a new generation of mTOR inhibitors. Nat. Rev. Drug Discov. 10, 868-880
74. Morgan-Warren, P.J. et al. (2013) Exploiting mTOR signaling: a novel translatable treatment strategy for traumatic optic neuropathy? Invest. Ophthalmol. Vis. Sci. 54, 6903-6916
75. Foster, K.G. and Fingar, D.C. (2010) Mammalian target of rapamycin (mTOR): conducting the cellular signaling symphony. J. Biol. Chem. 285, 14071-14077
76. Chong, Z.Z. et al. (2012) A critical kinase cascade in neurological disorders: PI 3-K, Akt, and mTOR. Future Neurol. 7, 733-748
77. Arsham, A.M. et al. (2003) A novel hypoxia-inducible factor-independent hypoxic response regulating mammalian target of rapamycin and its targets. J. Biol. Chem. 278, 29655-29660
78. Brugarolas, J. et al. (2004) Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1/TSC2 tumor suppressor complex. Genes Dev. 18, 2893-2904
79. Reiling, J.H. and Hafen, E. (2004) The hypoxia-induced paralogs Scylla and Charybdis inhibit growth by down-regulating S6 K activity upstream of TSC in Drosophila. Genes Dev. 18, 2879-2892
80. Johnson, S.C. et al. (2013) mTOR is a key modulator of ageing and age-related disease. Nature 493, 338-345
81. Laplante, M. and Sabatini, D.M. (2012) mTOR signaling in growth control and disease. Cell 149, 274-293
82. Maiese, K. et al. (2013) mTOR: on target for novel therapeutic strategies in the nervous system. Trends Mol. Med. 19, 51-60
83. Hudson, C.C. et al. (2002) Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin. Mol. Cell Biol. 22, 7004-7014
84. Polak, P. et al. (2008) Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab. 8, 399-410
85. Cunningham, J.T. et al. (2007) mTOR controls mitochondrial oxidative function through a YY1-PGC-1alpha transcriptional complex. Nature 450, 736-740
86. Bonawitz, N.D. et al. (2007) Reduced TOR signaling extends chronological life span via increased respiration and upregulation of mitochondrial gene expression. Cell Metab. 5, 265-277
87. del Olmo-Aguado, S. et al. (2013) RTP801 immunoreactivity in retinal ganglion cells and its down-regulation in cultured cells protect them from light and cobalt chloride. Brain Res. Bull. 98, 132-144
88. Kitaoka, Y. et al. (2013) Axonal protection by Nmnat3 overexpression with involvement of autophagy in optic nerve degeneration. Cell Death Dis. 4, e860
89. Kolosova, N.G. et al. (2012) Prevention of age-related macular degeneration-like retinopathy by rapamycin in rats. Am. J. Pathol. 181, 472-477
90. Ozaki, H. et al. (2000) Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am. J. Pathol. 156, 697-707
91. Bird, A.C. (2010) Therapeutic targets in age-related macular disease. J. Clin. Invest. 120, 3033-3041
92. Boulton, M. et al. (2001) Retinal photodamage. J. Photochem. Photobiol. B 64, 144-161
93. Bell, J.E. and Hall, C. (1981) Hemoproteins. In Spectroscopy in Biochemistry (Bell, J.E., ed.), pp. 42-46, CRC Press Inc.
94. Karu, T.I. et al. (2004) Photobiological modulation of cell attachment via cytochrome C oxidase. Photochem. Photobiol. Sci. 3, 211-216
95. Ortiz de Montellano, P.R. (1995) The 1994 Bernard B. Brodie Award Lecture. Structure, mechanism, and inhibition of cytochrome P450. Drug Metab. Dispos. 23, 1181-1187
96. Muñoz, M.A. et al. (2011) Different cell death mechanisms are induced by a hydrophobic flavin in human tumor cells after visible light irradiation. J. Photochem. Photobiol. B 103, 57-67
97. 2 in mammalian cells. Proc. Natl. Acad. Sci. U. S. A. 96, 6255-6260
98. García, J. and Silva, E. (1997) Flavin-sensitized photooxidation of amino acids present in a parenteral nutrition infusate: protection by ascorbic acid. J. Nutr. Biochem. 8, 341-345
99. Whelan, H.T. et al. (2001) Effect of NASA light-emitting diode irradiation on wound healing. J. Clin. Laser Med. Surg. 19, 305-314
100. Eells, J.T. et al. (2004) Mitochondrial signal transduction in accelerated wound and retinal healing by near-infrared light therapy. Mitochondrion 4, 559-567
101. Begum, R. et al. (2013) Treatment with 670 nm light up regulates cytochrome C oxidase expression and reduces inflammation in an age-related macular degeneration model. PLoS One 8, e57828
102. Kokkinopoulos, I. et al. (2013) Age-related retinal inflammation is reduced by 670 nm light via increased mitochondrial membrane potential. Neurobiol. Aging 34, 602-609
103. Rutar, M. et al. (2012) 670-nm light treatment reduces complement propagation following retinal degeneration. J. Neuroinflamm. 9, 257
104. del Olmo-Aguado, S. et al. (2012) Light might directly affect retinal ganglion cell mitochondria to potentially influence function. Photochem. Photobiol. 88, 1346-1355
105. Ying, R. et al. (2008) Pretreatment with near-infrared light via light-emitting diode provides added benefit against rotenone- and MPP+-induced neurotoxicity. Brain Res. 1243, 167-173
106. Liang, H.L. et al. (2006) Photobiomodulation partially rescues visual cortical neurons from cyanide-induced apoptosis. Neuroscience 139, 639-649
107. Wong-Riley, M.T. et al. (2005) Photobiomodulation directly benefits primary neurons functionally inactivated by toxins: role of cytochrome C oxidase. J. Biol. Chem. 280, 4761-4771
108. Simunovic, Z. et al. (2000) Wound healing of animal and human body sport and traffic accident injuries using low-level laser therapy treatment: a randomized clinical study of seventy-four patients with control group. J. Clin. Laser Med. Surg. 18, 67-73
109. Oron, U. et al. (2001) Low-energy laser irradiation reduces formation of scar tissue after myocardial infarction in rats and dogs. Circulation 103, 296-301
110. Karu, T. (1999) Primary and secondary mechanisms of action of visible to near-IR radiation on cells. J. Photochem. Photobiol. B 49, 1-17
111. Eells, J.T. et al. (2003) Therapeutic photobiomodulation for methanol-induced retinal toxicity. Proc. Natl. Acad. Sci. U. S. A. 100, 3439-3444
112. Huang, L. et al. (2012) Type I and type II mechanisms of antimicrobial photodynamic therapy: an in vitro study on gram-negative and gram-positive bacteria. Lasers Surg. Med. 44, 490-499
113. Wu, Q. et al. (2012) Low-level laser therapy for closed-head traumatic brain injury in mice: effect of different wavelengths. Lasers Surg. Med. 44, 218-226
114. Albarracin, R. et al. (2011) Photobiomodulation protects the retina from light-induced photoreceptor degeneration. Invest. Ophthalmol. Vis. Sci. 52, 3582-3592
115. Albarracin, R. and Valter, K. (2012) 670 nm red light preconditioning supports Muller cell function: evidence from the white light-induced damage model in the rat retina. Photochem. Photobiol. 88, 1418-1427
116. Rojas, J.C. et al. (2008) Neuroprotective effects of near-infrared light in an in vivo model of mitochondrial optic neuropathy. J. Neurosci. 28, 13511-13521
117. Albarracin, R. et al. (2013) 670 nm light mitigates oxygen-induced degeneration in C57BL/6J mouse retina. BMC Neurosci. 14, 125
118. Ishiguro, M. et al. (2010) Effect of near-infrared light-emitting diodes on nerve regeneration. J. Orthop. Sci. 15, 233-239
119. Peoples, C. et al. (2012) Survival of dopaminergic amacrine cells after near-infrared light treatment in MPTP-treated mice. ISRN Neurol. 2012, 850150
120. Moro, C. et al. (2013) Photobiomodulation inside the brain: a novel method of applying near-infrared light intracranially and its impact on dopaminergic cell survival in MPTP-treated mice. J. Neurosurg. 120, 670-683